Cite
MLA Citation
Michael G Hanna et al.. “Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.” Lancet neurology, vol. 18, no. 9, 2019, pp. 834–844. http://access.bl.uk/ark:/81055/vdc_100089543368.0x000013